NCT02195544

Brief Summary

Study of prescription methods in everyday medical practice, tolerance profile and effect of Synvisc® until six months of follow-up.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P25-P50 for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 1998

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2000

Completed
14.3 years until next milestone

First Submitted

Initial submission to the registry

July 18, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 21, 2014

Completed
Last Updated

July 21, 2014

Status Verified

July 1, 2014

Enrollment Period

1.5 years

First QC Date

July 18, 2014

Last Update Submit

July 18, 2014

Conditions

Outcome Measures

Primary Outcomes (3)

  • Change in clinical symptoms

    assessed via questionnaire

    up to 6 months

  • Amount of medication consumed

    up to 6 months

  • Patient satisfaction on a 4-point verbal rating scale

    up to 6 months

Secondary Outcomes (1)

  • Number of patients with adverse events

    up to 6 months

Study Arms (1)

Synvisc®

Drug: Synvisc®

Interventions

Synvisc®

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

rheumatological practice

You may qualify if:

  • not applicable

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Osteoarthritis

Interventions

hylan

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 18, 2014

First Posted

July 21, 2014

Study Start

October 1, 1998

Primary Completion

April 1, 2000

Last Updated

July 21, 2014

Record last verified: 2014-07